Centrum Medyczne Ksztalcenia Podyplomowego

Address: Ul. Ulica Marymoncka 99/103

Sponsor Overview

assignment

Specializations

Compulsive Sexual Behaviour Disorder

Clinical research in compulsive sexual behaviour disorder centers on pharmacological approaches aimed at reducing symptom severity, with interest in selective serotonin reuptake inhibitors, opioid receptor antagonists, and combination treatment strategies.

Escitalopram
Paroxetine
Naltrexone
Combination pharmacotherapy

The sponsor’s work in this area reflects a focus on psychiatric symptom control and the evaluation of treatment options for a behavior-related disorder with limited established therapeutic pathways.

Systemic Sclerosis

Research in systemic sclerosis is directed toward comparing targeted therapies for a complex autoimmune connective tissue disease, with attention to vascular, inflammatory, and fibrotic disease mechanisms.

Dapagliflozin
Tocilizumab
Autoimmune fibrosis
Inflammatory disease management

The therapeutic interest extends to treatment selection in patients with multisystem involvement, including domains relevant to internal medicine, rheumatology, and immune-mediated tissue remodeling.

Psychiatry and Behavioral Medicine

The sponsor is active in psychiatry through studies of symptom-focused drug treatment for disorders affecting behavior, impulse control, and mental health.

Behavioral symptom reduction
Psychopharmacology
Impulse control

This area highlights interest in clinical management of difficult-to-treat psychiatric conditions using established and repurposed medicines.

Rheumatology and Immunology

Within rheumatology and immunology, the sponsor’s research addresses chronic systemic disease with emphasis on immune modulation and long-term disease control.

Connective tissue disease
Immune-mediated inflammation
Fibrotic complications

These interests align with therapeutic evaluation in conditions where inflammation and fibrosis drive clinical burden and treatment complexity.

Trial Name	Country	Status
Comparison of treatment efficacy in the patients with Systemic sclerOsis: dapagliFlozin vs. Tocilizumab – a randomized head to head study	Poland	Not Yet Recruiting
Evaluation of Escitalopram, Naltrexone, and Their Combination Versus Placebo in Reducing Symptoms of Compulsive Sexual Behavior Disorder	Poland	Recruiting
Evaluation of Escitalopram, Paroxetine, Naltrexone, and Combination Therapy in Compulsive Sexual Behavior Disorder: A Randomized Controlled Trial	Poland	Not Yet Recruiting

Data & Insights

science

Molecule Portfolio

Compounds under investigation

Exclusive Molecules

out of 6 total (0% not shared with other sponsors)

This sponsor works with 6 molecules, of which 0 are not being studied by other sponsors.

hub

Site Partnerships

Collaboration with research centres

50%

Return partnership rate

1 of 2 sites collaborated multiple times

This sponsor has worked with 2 sites across their trial portfolio.

Therapeutic Focus

1.
Behavior and Behavior Mechanisms2 trials
38 other sponsors
2.
Mental Disorders2 trials
150 other sponsors
3.
Psychological Phenomena2 trials
20 other sponsors
4.
Musculoskeletal Diseases1 trial
238 other sponsors
5.
Skin and Connective Tissue Diseases1 trial
247 other sponsors

Partnered Research Centres

2 centres

location_city

assignment164

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji

Address: Ul. Woloska 137, 02-507 Warsaw

Learn morearrow_forward

location_city

assignment8

Szpital Bielanski Im.Ks.Jerzego Popieluszki samodzielny publiczny zakład opieki zdrowotnej

Address: Ul. Ceglowska 80, 01-809 Warsaw

Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Centrum Medyczne Ksztalcenia Podyplomowego.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.